HOME >> MEDICINE >> NEWS
Stereotactic lung cancer study produces positive initial results

The initial phase of a clinical trial for treatment of early stage lung cancer has produced positive results, according to an article appearing Nov. 11 in the journal Chest.

Researchers at Indiana University School of Medicine reported that the results of the extracranial stereotactic radioablation Phase I study for non-small cell lung cancer led the group to continue with the second phase of the clinical trial.

The initial phase tested the toxicity of increasingly large doses of radiation precisely focused on the lung tumor. Enrollment in the trial began in February 2000 and 37 patients participated. Researchers report that surprisingly high doses of radiation were tolerated and 87 percent of patients had positive tumor response. Only six patients had local recurrence of cancer, all treated at the lower dose levels used at the onset of the trial. Local recurrence has not been observed to date at the highest levels.

Patients enrolled in the Phase I study had to have stage I non-small cell lung cancer that was medically inoperable because of extenuating health problems. Non-small cell lung cancer accounts for 80 percent of all lung cancers and is the leading cause of cancer-related fatalities in the United States. In the U.S., 170,000 new cases of lung cancer are diagnosed each year and there are 157,000 deaths caused by the disease.

"Lung cancer patients frequently have other health problems such as emphysema or heart disease that makes them a bad risk for the standard surgical therapy for their disease," said Robert Timmerman, M.D., associate professor of radiation oncology and the principal author of the article.

Using a painless, minimally invasive therapy, Timmerman and his IU colleagues used 3-D imaging and stereotactic body mapping to precisely target the tumor down to a millimeter so that healthy tissue was spared the intensity of the photon radiation. Stereotactic mapping utilizes a specially designed, lightweigh
'"/>

Contact: Mary Hardin
mhardin@iupui.edu
317-274-7722
Indiana University
10-Nov-2003


Page: 1 2

Related medicine news :

1. Stereotactic body radiation therapy conference
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. International breast cancer prevention study launches in the United States and Canada
4. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
5. Cultural and social factors influence prostate cancer treatment
6. Primary care office strategies may increase colon cancer screening
7. Benefits of lung cancer screening with CT questioned
8. Three-year cervical cancer screening recommendations may be applicable for certain women with HIV
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
11. Employment prospects good for most cancer survivors -- but not all

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. is introducing ... present something whimsical and delicious in these complicated times,” he said, in announcing the ... 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are sourced in the Napa ...
(Date:5/21/2020)... ... May 21, 2020 , ... In response to the Coronavirus ... that allows users to open swing-style doors without using their hands or fingertips. ... pull the door open using their forearm, wrist or elbow when entering or exiting ...
(Date:5/21/2020)... ... May 21, 2020 , ... Fujirebio Diagnostics, Inc., a consolidated ... announced today that Cigna has added ROMA® (Risk of Ovarian Malignancy Algorithm) to ... dedicated to improving the health, well-being, and peace of mind of the customers ...
(Date:5/21/2020)... CHICAGO (PRWEB) , ... May 21, 2020 , ... A ... receive a donation from the $5 million AbbVie COVID-19 Community Resilience Fund. The fund ... support the needs of their frontline homeless workers in service to vulnerable populations in ...
(Date:5/21/2020)... ... May 21, 2020 , ... In response to Michigan Governor ... May 28th and all businesses will be required to have covid-19 employee screening, ... , As an essential business, AmeriCare Medical began this precautionary process in early ...
Breaking Medicine News(10 mins):
(Date:5/30/2020)... ITASCA, Ill. (PRWEB) , ... May 29, 2020 , ... ... everywhere with a 7-day Father's Day Sweepstakes event . Fourteen lucky winners will ... Father's Day, June 21, 2020. Registered users may enter once each day during the ...
(Date:5/30/2020)... ... May 30, 2020 , ... Pregnancy is stressful already, and ... related to COVID-19. Recently, Wellness Expert Jamie Hess teamed with One A Day® ... and postpartum. , A video accompanying this announcement is available at: ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... patient-care products led M&S Technologies, leader and innovator in essential vision testing products, ... M&S Technologies ’ web-based Vision Testing has been released and considering the circumstances, ...
Breaking Medicine Technology:
Cached News: